Want to see TSE:DHB full AI Analyst Report?
DHB Stock Chart & Stats
C$0.14
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.14
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.10 - C$0.37
Previous CloseN/A
Volume20.60K
Average Volume (3M)26.13K
Market Cap
C$3.28M
Enterprise ValueC$2.98M
Total Cash (Recent Filing)C$2.64M
Total Debt (Recent Filing)C$2.33M
Price to Earnings (P/E)―
Beta1.81
Next Earnings
Oct 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding31,261,782
10 Day Avg. Volume58,945
30 Day Avg. Volume26,134
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)1.30
Price to Sales (P/S)0.41
P/FCF Ratio-7.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.01
Revenue Forecast (FY)C$14.12M
Bulls Say, Bears Say
Bulls Say
Gross Margin StrengthA ~45.5% gross margin indicates structurally profitable unit economics for DHB’s product portfolio. If maintained, this margin provides durable headroom to cover SG&A and R&D, supports pricing flexibility, and makes a path to operating profitability more achievable as scale or cost efficiencies are realized.
Positive Equity BufferA positive equity base (~$2.9M TTM) gives the company tangible balance-sheet support versus insolvency risk. This provides runway to execute turnaround initiatives, access to additional financing if needed, and a cushion to absorb near-term losses while pursuing margin recovery or commercial expansion.
Improving Cash Burn TrendSubstantial reduction in cash burn versus prior years signals progress in cost control and operational discipline. A sustained trend toward lower negative cash flow increases the likelihood of reaching self-funding operations, lowers refinancing risk, and reflects improving execution on commercialization or expense management.
Bears Say
Material Revenue DeclineA 14.1% TTM revenue decline is a durable concern: shrinking top-line reduces operating leverage, undermines scale benefits, and raises the bar for reattaining profitability. Persistent revenue weakness can erode distributor confidence, limit reinvestment capacity, and make margins harder to sustain long-term.
Ongoing UnprofitabilitySustained negative operating and net margins (~-9%) indicate the business has not yet converted healthy gross margins into operating profits. Continued losses pressure retained earnings, limit strategic flexibility, and necessitate either consistent margin improvement or external funding to support growth initiatives over the medium term.
Negative Cash GenerationNegative operating and free cash flow (~-$0.3M TTM) is a persistent structural weakness. Ongoing cash deficits force reliance on financing, constrain marketing and product investment, and elevate execution risk; without sustained positive cash generation the company’s ability to scale or absorb shocks is limited.
Delivra Health Brands News
DHB FAQ
What was Delivra Health Brands’s price range in the past 12 months?
Delivra Health Brands lowest stock price was C$0.10 and its highest was C$0.37 in the past 12 months.
What is Delivra Health Brands’s market cap?
Delivra Health Brands’s market cap is C$3.28M.
When is Delivra Health Brands’s upcoming earnings report date?
Delivra Health Brands’s upcoming earnings report date is Oct 23, 2026 which is in 112 days.
How were Delivra Health Brands’s earnings last quarter?
Delivra Health Brands released its earnings results on May 29, 2026. The company reported -C$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.03.
Is Delivra Health Brands overvalued?
According to Wall Street analysts Delivra Health Brands’s price is currently Overvalued.
Does Delivra Health Brands pay dividends?
Delivra Health Brands does not currently pay dividends.
What is Delivra Health Brands’s EPS estimate?
Delivra Health Brands’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Delivra Health Brands have?
Delivra Health Brands has 31,261,782 shares outstanding.
What happened to Delivra Health Brands’s price movement after its last earnings report?
Delivra Health Brands reported an EPS of -C$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Delivra Health Brands?
Currently, no hedge funds are holding shares in TSE:DHB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Delivra Health Brands
Based in Vancouver, Canada, Delivra Health Brands Inc., through its various subsidiaries, distributes an assortment of lifestyle and wellness goods to a global clientele of consumers and medical patients within regulated jurisdictions. The firm's product line includes cannabis, liquid sleep supplements, powdered sleep aids, edible gummies, and topical pain relief solutions. These items are available under well-known brand labels like LivRelief, Dream Water, and LivRelief Infused. The company was formerly recognized as Harvest One Cannabis Inc.
Technical Analysis
Options Prices
Currently, No data available
---